Relationships of apelin concentration and APLN T-1860C polymorphism with obesity in Thai children

Kanjana Suriyaprom1, Banchamaphon Pheungruang2, Rungsunn Tungtrongchitr2

  • 1Faculty of Medical Technology, Rangsit University, Paholyothin Road, Mueang Pathum Thani district, Pathum Thani, 12000, Thailand. kanjana.su@rsu.ac.th.

BMC Pediatrics
|October 1, 2020
PubMed

Insights

Childhood obesity is linked to lower apelin levels and specific genetic variations. The APLN T-1860C gene variant may increase obesity risk in Thai girls.

Area of Science:

  • Endocrinology
  • Genetics
  • Pediatrics

Background:

  • Childhood obesity is a significant global health concern.
  • The apelin system plays a role in regulating feeding behavior and energy balance.
  • Apelin is distributed in the central nervous system, influencing homeostasis.

Purpose of the Study:

  • To investigate apelin concentrations and cardiometabolic markers in obese versus non-obese Thai children.
  • To determine the association of APLN T-1860C and APLNR G212A gene polymorphisms with apelin levels and obesity in Thai children.

Main Methods:

  • A case-control study involving 325 Thai children (198 obese, 127 non-obese).
  • Measurement of anthropometric-cardiometabolic variables and apelin concentration.
  • Genotyping using polymerase chain reaction-restriction fragment length polymorphism for APLN T-1860C and APLNR G212A.

Main Results:

  • Obese children had lower apelin and HDL-C, but higher triglycerides, glucose, and lipid ratios.
  • Apelin levels negatively correlated with body size and cardiometabolic parameters.
  • APLN T-1860C polymorphism and apelin concentration were associated with obesity in female children; APLNR G212A showed no significant association.

Conclusions:

  • Apelin levels are associated with obesity and cardiometabolic parameters in Thai children.
  • The APLN T-1860C polymorphism may contribute to obesity susceptibility in Thai girls.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1000
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
134
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
17.4K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
96
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.2K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
115